| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $3.2M | -36.2% |
| SG&A Expense | $7.1M | +50.2% |
| Operating Income | -$10.8M | -2.8% |
| Pre-tax Income | -$11.5M | -14.4% |
| Income Tax | $0 | — |
| Net Income | -$11.5M | -14.4% |
| EPS (Diluted) | -$56.94 | +97.9% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Inventory | $0 | -100.0% |
| Current Assets | $3.4M | +13.2% |
| Total Assets | $4.5M | -34.1% |
| Current Liabilities | $605K | -33.0% |
| Long-term Debt | $0 | — |
| Total Liabilities | $1.9M | +72.8% |
| Stockholders' Equity | $2.6M | -54.8% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$7.4M | +22.5% |
| Capital Expenditures | $16K | -52.8% |
| Investing Cash Flow | -$13K | +48.2% |
| Financing Cash Flow | $7.8M | +3.9% |
| Free Cash Flow | -$7.4M | +22.6% |